Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 30 Records) |
Query Trace: Death and MTOR[original query] |
---|
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71. Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife |
Genetic Association between Akt1 Polymorphisms and Alzheimer's Disease in a Japanese Population. International journal of Alzheimer's disease 2011 2011 762471. Shibata Nobuto, Ohnuma Tohru, Kuerban Bolati, Komatsu Miwa, Baba Hajime, Arai He |
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (New York, N.Y.) 2011 1 331 (6021): 1199-203. Jiao Yuchen, Shi Chanjuan, Edil Barish H, de Wilde Roeland F, Klimstra David S, Maitra Anirban, Schulick Richard D, Tang Laura H, Wolfgang Christopher L, Choti Michael A, Velculescu Victor E, Diaz Luis A, Vogelstein Bert, Kinzler Kenneth W, Hruban Ralph H, Papadopoulos Nickol |
Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study. The Lancet. Oncology 2013 Jan 14 (1): 81-7. Schutz Fabio A B, Pomerantz Mark M, Gray Kathryn P, Atkins Michael B, Rosenberg Jonathan E, Hirsch Michelle S, McDermott David F, Lampron Megan E, Lee Gwo-Shu Mary, Signoretti Sabina, Kantoff Philip W, Freedman Matthew L, Choueiri Toni |
Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma. Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2013 Mar 189 (3): 202-14. Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras K T, Fountzilas |
Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis. PloS one 2014 9 (5): e97085. Shao Jianbo, Li Ying, Zhao Peiwei, Yue Xin, Jiang Jun, Liang Xiaohui, He Xueli |
A GG allele of 3'-side AKT1 SNP is associated with decreased AKT1 activation and better prognosis of gastric cancer. Journal of cancer research and clinical oncology 2014 Aug 140 (8): 1399-411. Wang Xiaoting, Lin Youdong, Lan Fenghua, Yu Yinghao, Ouyang Xuenong, Wang Xuzhou, Huang Qiaojia, Wang Lie, Tan Jianming, Zheng Fe |
Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting. Polish journal of pathology : official journal of the Polish Society of Pathologists 2015 Jun 66 (2): 133-41. Adamczyk Agnieszka, Niemiec Joanna, Janecka Anna, Harazin-Lechowska Agnieszka, Ambicka Aleksandra, Grela-Wojewoda Aleksandra, Domaga?a-Haduch Ma?gorzata, Cedrych Ida, Majchrzyk Kaja, Kruczak Anna, Ry? Janusz, Jakubowicz Jer |
Mutational profiling of colorectal cancers with microsatellite instability. Oncotarget 2015 Oct . Lin Elaine I, Tseng Li-Hui, Gocke Christopher D, Reil Stacy, Le Dung T, Azad Nilofer S, Eshleman James |
Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups. Cancer immunology research 2016 Aug . De Velasco Guillermo, Miao Diana D, Voss Martin H, Hakimi A Ari, Hsieh James J, Tannir Nizar M, Tamboli Pheroze, Appleman Leonard J, Rathmell W Kimryn, Van Allen Eliezer, Choueiri Toni |
Targeted Exome Sequencing of the Cancer Genome in Patients with Very High-risk Bladder Cancer. European urology 2016 Aug . Longo Thomas, McGinley Kathleen F, Freedman Jennifer A, Etienne Wiguins, Wu Yuan, Sibley Alexander, Owzar Kouros, Gresham Jeremy, Moy Christopher, Szabo Stephen, Greshock Joel, Zhou Hui, Bai Yuchen, Inman Brant |
Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer. European journal of cancer (Oxford, England : 1990) 2017 11 87 189-198. Le Rhun Emilie, Bertrand Nicolas, Dumont Aurélie, Tresch Emmanuelle, Le Deley Marie-Cécile, Mailliez Audrey, Preusser Matthias, Weller Michael, Revillion Françoise, Bonneterre Jacqu |
Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations. Urologic oncology 2017 11 37 (1): 12-17. Manley Brandon J, Reznik Ed, Ghanaat Mazyar, Kashan Mahyar, Becerra Maria F, Casuscelli Jozefina, Tennenbaum Daniel, Redzematovic Almedina, Carlo Maria I, Sato Yusuke, Arcila Maria, Voss Martin H, Feldman Darren R, Motzer Robert J, Russo Paul, Coleman Jonathan, Hsieh James J, Hakimi Ari |
MiRNAs and their interplay with PI3K/AKT/mTOR pathway in ovarian cancer cells: a potential role in platinum resistance. Journal of cancer research and clinical oncology 2018 8 144 (12): 2313-2318. Gasparri Maria Luisa, Besharat Zein Mersini, Farooqi Ammad Ahmad, Khalid Sumbul, Taghavi Katayoun, Besharat Raad Aris, Sabato Claudia, Papadia Andrea, Panici Pierluigi Benedetti, Mueller Michael David, Ferretti Elisabet |
Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients. International journal of cancer 2018 Jul . Cheng Lei, Qiu Lixin, Zhang Ruoxin, Qian Danwen, Wang Mengyun, Sun Menghong, Zhu Xiaodong, Wang Yanong, Guo Weijian, Wei Qing |
Genetic Variants Within MTORC1 Genes Predict Gastric Cancer Prognosis in Chinese Populations. Journal of Cancer 2018 9 (8): 1448-1454. Xue Wenji, Wang Mengyun, Zhang Li, Gu Jianchun, Zhu Xueru, Wang Yiwei, Wang Ruifen, Wang Lifeng, Wang Weiye, Wang Xue-Feng, Mei Jia-Wei, Zheng Leizhen, Zhu Mei-Li |
Nuclear TP53: An unraveled function as transcriptional repressor of PINK1. Autophagy 2018 5 14 (6): 1099-1101. Checler Frédéric, Goiran Thomas, Alves da Costa Cristi |
Molecular characterization of metaplastic breast carcinoma via next-generation sequencing. Human pathology 2019 Apr 86 85-92. Zhai Jing, Giannini Gabriel, Ewalt Mark D, Zhang Elizabeth Y, Invernizzi Marta, Niland Joyce, Lai Lily |
Genetic Profiling of Breast Cancer with and Without Preexisting Metabolic Disease. Translational oncology 2019 12 13 (2): 245-253. Jing Wenjiang, Li Ling, Zhang Xiumei, Wu Shouxin, Zhao Jiangman, Hou Qunxing, Wu Haotian, Ma Wu, Li Shuheng, Liu Huimin, Yang Binh |
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG). ESMO open 2019 4 (5): e000525. Zarkavelis George, Kotoula Vassiliki, Kolliou Georgia-Angeliki, Papadopoulou Kyriaki, Tikas Ioannis, Karavasilis Vasilios, Samantas Epaminontas, Dervenis Christos, Efstratiou Ioannis, Nicolaou Irene, Apessou Dimitra, Kafiri Georgia, Koletsa Triantafyllia, Bompolaki Iliada, Rallis Grigorios, Batistatou Anna, Glantzounis George, Pectasides Dimitrios, Fountzilas George, Pentheroudakis Geor |
Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV- Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets. JCO precision oncology 2020 9 4 . Williams Erik A, Werth Adrienne J, Sharaf Radwa, Montesion Meagan, Sokol Ethan S, Pavlick Dean C, McLaughlin-Drubin Molly, Erlich Rachel, Toma Helen, Williams Kevin Jon, Venstrom Jeff M, Alexander Brian M, Shah Nikunj, Danziger Natalie, Hemmerich Amanda C, Severson Eric A, Killian Jonathan Keith, Lin Douglas I, Ross Jeffrey S, Tse Julie Y, Ramkissoon Shakti H, Mochel Mark C, Elvin Julia |
Characterization of genomic alterations and the significance of PI3K/mTOR pathway mutations and tumor mutational burden in non?small cell lung cancer. Oncology reports 2020 Mar . Hu Jing, Shang Yanhong, Shi Xiaoliang, Zhang Shuirong, Shi Junping, Yao Ming, Wang Aodi, Shou Tao, Shi Weiwei, Wang Kai, Liu Angen, Pan Xiaojie, Wang Yongj |
Antitumor activity and safety of sirolimus for solid tumors with PIK3CA mutations: A multicenter, open-label, prospective single-arm study (KM 02-01, KCSG UN17-16). Translational cancer research 2022 2 9 (5): 3222-3230. Byeon Seonggyu, Kang Myoung Joo, Choi Yoon Ji, Kim Yu Jung, Kim Miso, Yun Jina, Yi Seong Yoon, Kim Jin Young, Kim Seung Tae, Lee Jeey |
An MGMT Allelic Variant Can Affect Biochemical Relapse in Prostate Cancer Patients. Anticancer research 2022 12 43 (1): 369-379. Furini Hector Hugo, Fukushima Kevin Santiago DE Souza Quenzo, DE Nóbrega Monyse, DE Souza Marilesia Ferreira, Rodrigues Milene Roldão Souza, DE Mattos Beatriz Bocatte, Guembarovski Roberta Losi, Fuganti Paulo Emílio, Simão Andrea Name Colado, Flauzino Tamires, Cólus Ilce Mara DE Syll |
Clinical phenotypes and long-term outcome of kidney involvement in Erdheim-Chester histiocytosis. Kidney international 2022 11 103 (1): 177-186. Chazal Thibaud, Pegoraro Francesco, Manari Gaia, Bettiol Alessandra, Maniscalco Valerio, Gelain Elena, Charlotte Frédéric, Mazor Roei D, Renard-Penna Raphaele, Amoura Zahir, Cohen-Aubart Fleur, Haroche Julien, Izzedine Hassan, Vaglio Augus |
Remote modulation of WWOX by an intronic variant associated with survival of Chinese gastric cancer patients. International journal of cancer 2023 8 . Lei Cheng, Yuanyuan Chang, Zuguang Xia, Yizhen Liu, Xiao Liu, Liwen Xiong, Chenchen Liu, Xiaodong Zhu, Mengyun Wang, Lixin Q |
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM. JCO precision oncology 2023 6 7 e2300015. Anna-Elisa Heipertz, Kristian W Pajtler, Elke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, Till Milde, Barbara C Jones, Cecilia Zuliani, Caroline Hutter, Olli Lohi, Antonis Kattamis, Iwona Dachowska-Kalwak, Anna Nilsson, Nicolas U Gerber, Karin P S Langenberg, Bianca Goemans, C Michel Zwaan, Jan J Molenaar, Natalie Jäger, Uta Dirksen, Ruth Witt, Stefan M Pfister, David T W Jones, Annette Kopp-Schneider, Olaf Witt, Cornelis M van Tilbu |
BAP1-related signature predicts benefits from immunotherapy over VEGFR/mTOR inhibitors in ccRCC: a retrospective analysis of JAVELIN Renal 101 and checkmate-009/010/025 trials. Cancer immunology, immunotherapy : CII 2023 4 . Liu Kan, Huang Yan, Xu Yu, Wang Guoqiang, Cai Shangli, Zhang Xu, Shi Taopi |
MTOR gene variants are associated with severe COVID-19 outcomes: A multicenter study. International immunopharmacology 2023 11 125 (Pt B): 111155. Bruna Ramos Tosta, Ingrid Marins de Almeida, Laiane da Cruz Pena, Hatilla Dos Santos Silva, Fabiane S Reis-Goes, Nívia N Silva, João Victor Andrade Cruz, Mailane Dos Anjos Silva, Jéssica Francisco de Araújo, Juliana Lopes Rodrigues, Gabriella Oliveira, Ricardo Gassmann Figueiredo, Sara Nunes Vaz, Iris Montaño-Castellón, Daniele Santana, Fabyan Esberard de Lima Beltrão, Valdirene Leão Carneiro, Gubio Soares Campos, Carlos Brites, Vitor Fortuna, Camila Alexandrina Figueiredo, Soraya Castro Trindade, Helton Estrela Ramos, Ryan Dos Santos Cos |
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials. Gynecologic oncology 2024 4 183 103-114. Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, Neil T Phippen, Christopher M Tarney, Erica R Hope, Stuart S Winkler, Suzanne Jokajtys, Calen W Kucera, John K Chan, Michael T Richardson, Daniel S Kapp, Chad A Hamilton, Charles A Leath, Nathaniel L Jones, Rodney P Rocconi, John H Farley, Angeles Alvarez Secord, Casey M Cosgrove, Matthew A Powell, Ann Klopp, Joan L Walker, Gini F Fleming, Nicholas W Bateman, Thomas P Conrads, G Larry Maxwell, Kathleen M Dar |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: